Tilray Canada Ltd. has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart, Canadian retail pharmacy chain based in Toronto with more than 1,253 stores operating in nine provinces and two territories, and under the name Pharmaprix in Quebec.
Subject to Health Canada’s approval of Shoppers Drug Mart’s application to be a licensed producer, under the terms of the agreement the company will supply Shoppers Drug Mart with Tilray branded medical cannabis products. It is expected the products will be sold online, as Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.
Tilray is involved in global research, production, and distribution of medical cannabis and cannabinoids.
Tilray was the first licensed producer in North America to be EU GMP certified to produce medical cannabis. The company currently serves tens of thousands of patients, physicians, pharmacies, governments, hospitals, and researchers in eight countries spanning four continents through its affiliated entities in Australia and New Zealand (Tilray Australia New Zealand Pty Ltd), Canada (Tilray Canada Ltd), Germany (Tilray Deutschland GmbH), and Portugal (Tilray Portugal Unipessoal Lda).